HRP20150066T1 - Anti-malarijski agensi koji su inhibitori dihidroorotat dehidrogenaze - Google Patents

Anti-malarijski agensi koji su inhibitori dihidroorotat dehidrogenaze Download PDF

Info

Publication number
HRP20150066T1
HRP20150066T1 HRP20150066AT HRP20150066T HRP20150066T1 HR P20150066 T1 HRP20150066 T1 HR P20150066T1 HR P20150066A T HRP20150066A T HR P20150066AT HR P20150066 T HRP20150066 T HR P20150066T HR P20150066 T1 HRP20150066 T1 HR P20150066T1
Authority
HR
Croatia
Prior art keywords
compound
image
pharmaceutically acceptable
compound according
tautomers
Prior art date
Application number
HRP20150066AT
Other languages
English (en)
Croatian (hr)
Inventor
Pradipsinh K. Rathod
David Floyd
Jeremy Burrows
Alka Marwaha
Ramesh Gujjar
Jose Coteron-Lopez
Margaret Phillips
Susan A. Charman
David Matthews
Original Assignee
Board Of Regents Of The University Of Texas System
Monash University
Mmv Medicines For Malaria Venture
University Of Washington
Glaxosmithkline Investigacion Y Desarrollo, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Board Of Regents Of The University Of Texas System, Monash University, Mmv Medicines For Malaria Venture, University Of Washington, Glaxosmithkline Investigacion Y Desarrollo, S.L. filed Critical Board Of Regents Of The University Of Texas System
Publication of HRP20150066T1 publication Critical patent/HRP20150066T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HRP20150066AT 2009-09-29 2010-09-28 Anti-malarijski agensi koji su inhibitori dihidroorotat dehidrogenaze HRP20150066T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24686309P 2009-09-29 2009-09-29
EP10821105.3A EP2483274B1 (en) 2009-09-29 2010-09-28 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase
PCT/US2010/050532 WO2011041304A2 (en) 2009-09-29 2010-09-28 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase

Publications (1)

Publication Number Publication Date
HRP20150066T1 true HRP20150066T1 (hr) 2015-02-27

Family

ID=43826848

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20150066AT HRP20150066T1 (hr) 2009-09-29 2010-09-28 Anti-malarijski agensi koji su inhibitori dihidroorotat dehidrogenaze

Country Status (15)

Country Link
US (1) US9238653B2 (enExample)
EP (1) EP2483274B1 (enExample)
JP (1) JP5818266B2 (enExample)
CN (1) CN102741255B (enExample)
BR (1) BR112012007179B8 (enExample)
CA (1) CA2775354C (enExample)
DK (1) DK2483274T3 (enExample)
ES (1) ES2527835T3 (enExample)
HR (1) HRP20150066T1 (enExample)
ME (1) ME02020B (enExample)
PL (1) PL2483274T3 (enExample)
PT (1) PT2483274E (enExample)
SI (1) SI2483274T1 (enExample)
SM (1) SMT201500071B (enExample)
WO (1) WO2011041304A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY175865A (en) * 2013-12-19 2020-07-14 Novartis Ag [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis
EP3072894A1 (en) 2015-03-26 2016-09-28 Board Of Regents Of the University Of Texas System New substituted triazolopyrimidines as anti-malarial agents
EP3254679A1 (de) 2016-06-09 2017-12-13 Christian-Albrechts-Universität zu Kiel Wirkstoffe gegen protozoen und bakterien
EP3525786A4 (en) * 2016-10-12 2020-03-18 Merck Sharp & Dohme Corp. KDM5 INHIBITORS
EP3548035A4 (en) 2016-11-30 2020-07-22 Case Western Reserve University COMBINATIONS OF 15-PGDH INHIBITORS WITH CORCOSTEROIDS AND / OR TNF INHIBITORS AND THEIR USES
AU2018215678A1 (en) * 2017-02-06 2019-08-22 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
JP7178360B2 (ja) 2017-04-07 2022-11-25 ケース ウエスタン リザーブ ユニバーシティ 冠状動脈障害を治療するための短鎖型デヒドロゲナーゼ活性の阻害剤
IL321451A (en) 2018-11-21 2025-08-01 Univ Case Western Reserve Compositions and methods of modulating short-chain dehydrogenase activity
EP3842100A1 (en) * 2019-12-24 2021-06-30 The Board Of Regents Of The University Of Texas System Anti-malarial agents
MX2022010258A (es) 2020-02-21 2023-01-24 Univ Case Western Reserve Composiciones y métodos para tratar la lesión renal.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208693B (en) 1991-02-22 1993-12-28 Egyt Gyogyszervegyeszeti Gyar Process for producing 1,2,4-triazolo (1,5-a) pyrimidinis derivatives and their carbicycli-tetrahydro-thiofurane-tetrahydrothiopyrane-, or tetrahydropyridine- condensated derivatives or medical preparatives containing them
US5478825A (en) 1991-02-22 1995-12-26 Egis Gyogyszergyar 5-(substituted amino)-1,2,4-triazolo (1,5-A) pyrimidine derivatives
US8490825B2 (en) 1999-12-08 2013-07-23 Metal Container Corporation Can lid closure and method of joining a can lid closure to a can body
CZ294535B6 (cs) * 2001-08-02 2005-01-12 Ústav Experimentální Botaniky Avčr Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
US20080027079A1 (en) * 2006-06-22 2008-01-31 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
MX2009007944A (es) * 2007-01-26 2009-08-07 Irm Llc Compuestos y composiciones de purina como inhibidores de quinasa para el tratamiento de enfermedades relacionadas con plasmodium.
WO2009082691A1 (en) * 2007-12-21 2009-07-02 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity

Also Published As

Publication number Publication date
PL2483274T3 (pl) 2015-04-30
BR112012007179B1 (pt) 2020-12-01
CA2775354A1 (en) 2011-04-07
BR112012007179B8 (pt) 2021-05-25
US20120302586A1 (en) 2012-11-29
HK1174639A1 (en) 2013-06-14
SMT201500071B (it) 2015-05-05
EP2483274A4 (en) 2013-03-06
CN102741255A (zh) 2012-10-17
JP5818266B2 (ja) 2015-11-18
BR112012007179A2 (pt) 2017-07-25
SI2483274T1 (sl) 2015-02-27
PT2483274E (pt) 2015-02-04
EP2483274B1 (en) 2014-10-29
WO2011041304A3 (en) 2011-08-04
ME02020B (me) 2015-05-20
JP2013506004A (ja) 2013-02-21
BR112012007179A8 (pt) 2018-01-23
US9238653B2 (en) 2016-01-19
ES2527835T3 (es) 2015-01-30
CA2775354C (en) 2019-01-15
DK2483274T3 (en) 2015-01-19
CN102741255B (zh) 2015-10-07
WO2011041304A2 (en) 2011-04-07
EP2483274A2 (en) 2012-08-08

Similar Documents

Publication Publication Date Title
ME02020B (me) Anti-malarijski agensi kao inhibitori dihidroorotat dehidrogenaze
JP2013506004A5 (enExample)
JOP20220221B1 (ar) مشتقات باي أريل كمثبطات تداخل بروتين-بروتين yap/taz-tead
HRP20171899T1 (hr) N-acilsulfonamidni promotori apoptoze
Yu et al. Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability
HRP20090459T1 (hr) Aminofenil derivati kao novi inhibitori histonskih deacetilaza
JP2009541223A5 (enExample)
MA27600A1 (fr) Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FI3702351T3 (fi) MEK-inhibiittorin käsittävä koostumus
JP2013528600A5 (enExample)
WO2010095041A2 (en) Compositions, methods, and kits for treating influenza viral infections
RU2006118789A (ru) 2-цианопирролидинкарбоксамидное соединение
EP3177609A1 (en) Indoles for use in influenza virus infection
HRP20200274T1 (hr) Terapeutski aktivni spojevi i postupci njihove uporabe
HRP20120494T1 (hr) Derivati purina za uporabu kao agonista adenozin a2a receptora
CO5570677A2 (es) Quinolinilpirrolopirazoles
BRPI0506622A (pt) éster biciclo derivado; um intermediário na produção do éster biciclo derivado; produto farmacêutico contendo um ingrediente ativo do éster biciclo derivado; inibidor dpp-iv contendo um ingrediente ativo do éster biciclo derivado; agente terapêutico para uma doença envolvendo dpp-iv contendo um ingrediente ativo do éster biciclo derivado, e agente terapêutico
HRP20141108T1 (hr) Antagonisti piperidinon karboksamid azaindan cgrp receptora
HRP20192020T1 (hr) Derivati heteroarila i njihova upotreba
AR056198A1 (es) Un proceso para la fabricacion de una composicion farmaceutica tipo tableta
HRP20171824T1 (hr) (TIENO[2,3-b][1,5]BENZOKSAZEPIN-4-IL)PIPERAZIN-1-ILNI SPOJEVI S DVOJNOM AKTIVNOŠĆU INVERZNIH AGONISTA H1 I ANTAGONISTA 5-HT2A
MA34776B1 (fr) Nouvelle association entre le 4-(3-(cis-hexahydrocyclopenta[c] pyrrol-2(1h)-yl]propoxy) benzamide et un inhibiteur de l'acetylcholinesterase et les compositions pharmaceutiques qui la contiennent
NO20042187L (no) Antranilsyreamider og deres anvendelse som VEGF-reseptor tyrorsinkinaseinhibitorer.
CL2025000536A1 (es) Inhibidores de topoisomerasa-1 derivados de exatecán composiciones farmacéuticas y sus usos.
HRP20120257T1 (hr) Antagonisti receptora 5-ht7